RT Journal Article
SR Electronic
T1 Alterations in CD39/CD73 Axis of T cells associated with COVID-19 severity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.18.21263782
DO 10.1101/2021.09.18.21263782
A1 Dorneles, Gilson P
A1 Teixeira, Paula C
A1 da Silva, Igor M
A1 Schipper, Lucas L
A1 Santana Filho, Paulo C
A1 Rodrigues Júnior, Luiz Carlos
A1 Bonorino, Cristina
A1 Peres, Alessandra
A1 da Fonseca, Simone Gonçalves
A1 Monteiro, Marta Chagas
A1 Boeck, Carina Rodrigues
A1 Eller, Sarah
A1 Oliveira, Tiago F
A1 Wendland, Eliana M
A1 Romão, Pedro R T
YR 2021
UL http://medrxiv.org/content/early/2021/09/22/2021.09.18.21263782.abstract
AB Purinergic signaling modulates immune function and is involved in the immunopathogenesis of several viral infections. This study aimed to investigate alterations in purinergic pathways in COVID-19 patients. We evaluated the systemic levels of adenine-based purines, the frequencies of CD4+ and CD8+ T cells expressing CD39/CD73 ectonucleotidases, CD8+CD27-/+CD28-/+ T cells expressing PD-1 and the rates of lymphocyte apoptosis in the peripheral blood of patients with mild or severe COVID-19. Lower plasma ATP and adenosine levels were identified in mild and severe COVID-19 patients associated with higher systemic levels of IL-6, IL-10 and IL-17A compared to health controls. Mild COVID-19 patients presented lower frequencies of CD4+CD25+CD39+ (activated/memory Treg) and CD4+CD25+CD39+CD73+ T cells, and increased frequencies of high differentiated (CD27-CD28-) CD8+T cells compared to health controls. Severe COVID-19 patients also showed higher frequencies of CD4+CD39+, CD4+CD25-CD39+ (memory T effector cell), high differentiated CD8+ T cells (CD27-CD28-) and diminished frequencies of CD4+CD73+, CD4+CD25+CD39+ mTreg, CD4+CD25+CD39+CD73+, CD8+CD73+ and low-differentiated CD8+ T cells (CD27+CD28+) in the blood in relation to mild COVID-19 patients and controls. Moreover, severe COVID-19 patients presented higher expression of PD-1 on low-differentiated CD8+ T cells. Both severe and mild COVID-19 patients presented higher frequencies of CD4+Annexin-V+ and CD8+Annexin-V+ T cells, showing increased T cell apoptosis. Together, these data add new knowledge regarding the immunopathology of COVID-19 through purinergic regulation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe are grateful to the Brazilian agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Finance Code 001). This study was supported in part by the Hospital Moinhos de Vento through the Program for Supporting the Institutional Development of the Public Health System (PROADISUS), supported by the Ministry of Health of Brazil. GPD is supported by postdoctoral fellowship from CAPES. PRTR, CB and CRB are grateful to CNPq for the PQ productivity scholarship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Moinhos de Vento Ethics Committee N 3977144 (Porto Alegre/Brazil) and informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available when requested.